“Many conditions can arise during normal life, whether a vaccine is administered, but it remains important to report any new serious or unexpected events so that safety can be appropriately monitored,” the administration said. It has not been publicly confirmed which vaccine the woman received.
“The blood clotting disorders being investigated in connection with the AstraZeneca vaccine are very rare and differ from common blood clots or venous thromboembolism, which occur in around 50 Australians every day,” the Therapeutic Goods Administration of Australia said.
“The clotting disorder being investigated in connection with the AstraZeneca vaccine, which is now referred to as ‘thrombosis with thrombocytopenia syndrome’, has been confirmed in only two cases out of over 700,000 people who have received the AstraZeneca vaccine in Australia.”
Australians under the age of 50 were last week warned off receiving the AstraZeneca vaccine after a link was confirmed between the jab and rare blood clots.
Two people have developed blood clots likely linked to their AstraZeneca jab in Australia – a woman in Western Australia and a man in Victoria, aged in their 40s.
(Edited by Vaibhav Vishwanath Pawar and Ritaban Misra. Map by Urvashi Makwana)
